Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,175 | 560 | 99.6% |
| Education | $40.21 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,296 | 115 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,348 | 67 | $0 (2024) |
| Lilly USA, LLC | $1,271 | 76 | $0 (2024) |
| Novo Nordisk Inc | $687.38 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $580.35 | 38 | $0 (2022) |
| PFIZER INC. | $518.64 | 35 | $0 (2021) |
| ABBVIE INC. | $381.51 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $366.23 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $298.31 | 15 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $297.34 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $971.23 | 49 | Amgen Inc. ($221.39) |
| 2023 | $1,237 | 57 | Lilly USA, LLC ($288.43) |
| 2022 | $1,596 | 88 | Amgen Inc. ($362.28) |
| 2021 | $1,231 | 70 | Amgen Inc. ($282.54) |
| 2020 | $752.05 | 48 | Amgen Inc. ($189.57) |
| 2019 | $1,240 | 79 | Lilly USA, LLC ($275.69) |
| 2018 | $1,415 | 77 | Amgen Inc. ($476.35) |
| 2017 | $1,772 | 97 | Daiichi Sankyo Inc. ($298.31) |
All Payment Transactions
565 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Oncology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Inflammation | ||||||
| 08/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Obesity | ||||||
| 08/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Bone Health | ||||||
| 07/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Obesity | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Obesity | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Bone Health | ||||||
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Gastroenterology | ||||||
| 05/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 438 | 967 | $154,335 | $57,204 |
| 2022 | 9 | 565 | 1,055 | $178,931 | $61,769 |
| 2021 | 6 | 478 | 1,030 | $182,305 | $65,966 |
| 2020 | 10 | 575 | 1,031 | $173,610 | $54,702 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 336 | $86,016 | $29,413 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $25,286 | $12,072 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 176 | $30,448 | $10,620 | 34.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 129 | 346 | $5,190 | $2,906 | 56.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $7,395 | $2,192 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 398 | $101,901 | $33,716 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $23,672 | $11,354 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 111 | $19,203 | $7,171 | 37.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 94 | 94 | $17,954 | $5,086 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $7,888 | $1,995 | 25.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 121 | 282 | $4,230 | $831.94 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 26 | $1,508 | $769.60 | 51.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 23 | 25 | $700.00 | $686.00 | 98.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 11 | 15 | $1,875 | $159.70 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 464 | $118,784 | $42,270 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 89 | 89 | $23,941 | $11,868 | 49.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 84 | 84 | $15,978 | $4,681 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 68 | $11,489 | $3,319 | 28.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 22 | $7,568 | $2,919 | 38.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 114 | 303 | $4,545 | $909.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 362 | $92,672 | $28,203 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 85 | 85 | $22,865 | $9,935 | 43.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 49 | $16,856 | $5,455 | 32.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 64 | 65 | $8,125 | $4,496 | 55.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 77 | $12,335 | $3,343 | 27.1% |
About Dr. Nicholas Carulli, MD
Dr. Nicholas Carulli, MD is a Internal Medicine healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871682237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Carulli, MD has received a total of $10,215 in payments from pharmaceutical and medical device companies, with $971.23 received in 2024. These payments were reported across 565 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,175).
As a Medicare-enrolled provider, Carulli has provided services to 2,056 Medicare beneficiaries, totaling 4,083 services with total Medicare billing of $239,642. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Vancouver, WA
- Active Since 10/12/2006
- Last Updated 11/17/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871682237
Products in Payments
- FARXIGA (Drug) $833.89
- TRULICITY (Drug) $653.59
- EVENITY (Biological) $647.54
- Repatha (Biological) $623.74
- CHANTIX (Drug) $427.37
- Prolia (Biological) $400.03
- Otezla (Drug) $349.29
- Ozempic (Drug) $321.86
- Kerendia (Drug) $297.34
- ENTRESTO (Drug) $277.12
- Aimovig (Biological) $275.58
- XARELTO (Drug) $245.20
- ELIQUIS (Drug) $213.56
- Movantik (Drug) $202.93
- XIFAXAN (Drug) $193.28
- INVOKANA (Drug) $190.05
- MOUNJARO (Drug) $188.77
- BREZTRI (Drug) $180.38
- QULIPTA (Drug) $171.04
- Carospir (Drug) $162.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Vancouver
Dr. Jaime Aranda-Michel, Md, MD
Internal Medicine — Payments: $190,413
Dr. Nicholas Wysham, M.d, M.D
Internal Medicine — Payments: $115,959
Dr. Nora Bucher, Md, MD
Internal Medicine — Payments: $92,601
Dr. Troy Dillard, Md, MD
Internal Medicine — Payments: $25,011
Dr. Kameron Ferdowsali, M.d, M.D
Internal Medicine — Payments: $23,197
Mahesh Dangal, M.d, M.D
Internal Medicine — Payments: $19,705